Page 52 - RCPA Annual Report 2016-17

50
Notes to the Financial Statements
THE ROYAL COLLEGE OF PATHOLOGISTS OF AUSTRALASIA
ABN 52 000 173 231
NOTES TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 30 JUNE 2017
5. Profit (continued)
(b) Significant Revenues and Expenses
The following revenue and expenses are relevant in explaining the financial performance of the College:
2017 2016 $$
Included in revenue and other expenses per the Statement of Profit or Loss and Other Comprehensive Income are the following revenues and expenses resulting from specific grants received by the College. Grant revenue is recognised as expenses are incurred, any excess of Grant receipts over Grant expenses is recognised in the Statement of Financial
Position as Deferred Grant Income. Unexpended Grant income is returned to provider.
the Grant
338,725 338,725 635,900
117,303 117,303 232,697
25,000
25,000 (15,910)
-
- 23,915
97,909 97,909 -
-
- 82,331
-
- 19,742
Grant - Standardisation of Pathology Information Terminology and Units Part 1 and 2
Revenues
Expenses
Deferred Grant Income
Grant – Pathology Workforce Change - National Cervical Screening Program
Revenues
Expenses
Deferred Grant Income
Grant – Medical Services Advisory Committee Revenues
Expenses
Deferred Grant income
Grant - Electronic Decision Support - Pathology Requesting Revenues
Expenses
Deferred Grant Income
Grant - Common Sense Pathology Revenues
Expenses
Deferred Grant Income
Grant – Structured Reporting of Cancer funding for an additional protocol
Revenues
Expenses
Deferred Grant income
622,903 622,903 12,998
350,543 350,543 112,154
- - -
-
- 23,915
- - -
134,310 134,310 2,565
Other Grants
Revenues - Expenses -
Deferred Grant Income
19,742
13
ANNUAL REPORT • 2016 - 2017